Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | September 25, 2026 | September 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 25, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 1,067 |
Reported balance
After 2026-08-18 transaction · row 1
1 source rowRow 1 · 2026-08-18 · Other · Disposed 2,553.779 · Balance 1,067 F1: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Trust | 262,996.092 |
Reported balance
After 2026-08-18 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-18 · Other · Acquired 2,553.779 · Balance 262,996.092 F1: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Trust | 263,288.642 |
Reported balance
After 2026-09-25 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-25 · Purchase · Acquired 292.55 · Balance 263,288.642 F2: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934.
F2: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 28, 2026 20:15 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 292.55 | $268.76 | $78,625.74 |
DisclosureSEC source: 0001212852-26-000005 · wk-form4_1790626530.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 263,288.642 F2 · shares: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan. Read SEC document |
| August 18, 2026 Filed Sep 28, 2026 20:15 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 2,553.779 | $0.00 | $0.00 |
DisclosureSEC source: 0001212852-26-000005 · wk-form4_1790626530.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 262,996.092 F1 · kind: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| August 18, 2026 Filed Sep 28, 2026 20:15 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 2,553.779 | $0.00 | $0.00 |
DisclosureSEC source: 0001212852-26-000005 · wk-form4_1790626530.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,067 F1 · kind: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 324.782 | $230.57 | $74,884.99 |
DisclosureSEC source: 0001212852-26-000003 · wk-form4_1782764934.xml · nonDerivative · entry 4 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 260,442.322 F3 · shares: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 14.318 | $230.57 | $3,301.30 |
DisclosureSEC source: 0001212852-26-000003 · wk-form4_1782764934.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,620.768 F3 · shares: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 422 | $225.00 | $94,950.00 |
DisclosureSEC source: 0001212852-26-000003 · wk-form4_1782764934.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,606.45 F2 · kind: At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 645 | $225.00 | $145,125.00 |
DisclosureSEC source: 0001212852-26-000003 · wk-form4_1782764934.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,184.45 F1 · kind: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:30 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 62.06 | $297.38 | $18,455.40 |
DisclosureSEC source: 0001628280-26-022028 · wk-form4_1774901973.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,539.45 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:30 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 1,407.78 | $297.38 | $418,645.62 |
DisclosureSEC source: 0001628280-26-022028 · wk-form4_1774901973.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 260,117.54 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 19:30 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 251.21 | $278.37 | $69,929.33 |
DisclosureSEC source: 0001628280-26-000085 · wk-form4_1767382233.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 258,709.76 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 19:30 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 11.06 | $278.37 | $3,078.77 |
DisclosureSEC source: 0001628280-26-000085 · wk-form4_1767382233.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,477.39 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| September 25, 2025 Filed Sep 27, 2025 00:46 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 11.57 | $265.22 | $3,068.58 |
DisclosureSEC source: 0001628280-25-042985 · wk-form4_1758933959.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,466.33 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| September 25, 2025 Filed Sep 27, 2025 00:46 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 262.465 | $265.19 | $69,603.09 |
DisclosureSEC source: 0001628280-25-042985 · wk-form4_1758933959.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 258,458.552 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:11 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 11.29 | $270.53 | $3,054.28 |
DisclosureSEC source: 0001156375-25-000139 · wk-form4_1750975894.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,454.76 F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:11 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 256.097 | $270.53 | $69,281.92 |
DisclosureSEC source: 0001156375-25-000139 · wk-form4_1750975894.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 258,196.087 F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 879 | $273.03 | $239,993.37 |
DisclosureSEC source: 0001156375-25-000139 · wk-form4_1750975894.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 257,939.99 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| March 26, 2025 Filed Mar 27, 2025 23:19 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 11.58 | $262.62 | $3,041.14 |
DisclosureSEC source: 0001156375-25-000090 · wk-form4_1743117548.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,443.47 Read SEC document |
| March 26, 2025 Filed Mar 27, 2025 23:19 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 262.56 | $262.62 | $68,953.51 |
DisclosureSEC source: 0001156375-25-000090 · wk-form4_1743117548.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 257,060.99 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| January 16, 2025 Filed Jan 17, 2025 17:12 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 60.35 | $227.96 | $13,757.39 |
DisclosureSEC source: 0001156375-25-000004 · wk-form4_1737133962.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,432.19 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| January 16, 2025 Filed Jan 17, 2025 17:12 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 1,368.84 | $227.96 | $312,040.77 |
DisclosureSEC source: 0001156375-25-000004 · wk-form4_1737133962.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 256,805.15 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| January 16, 2025 Filed Mar 27, 2025 22:55 UTC Amendment | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 60.05 | $227.96 | $13,689.00 |
DisclosureSEC source: 0001156375-25-000088 · wk-form4a_1743116100.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,431.89 F1 · shares: The original Form 4 filed on January 17, 2025 is being amended to reflect an update in the number of shares acquired on January 16, 2025 pursuant to a dividend reinvestment plan administered by the reporting person's broker. Subsequent to the purchase and the filing of the original Form 4, an adjustment in the number of shares received by the reporting person was made by the broker. This Form 4/A is being filed to update the number of securities held directly and indirectly following this purchase. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| January 16, 2025 Filed Mar 27, 2025 22:55 UTC Amendment | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 1,362.12 | $227.96 | $310,508.88 |
DisclosureSEC source: 0001156375-25-000088 · wk-form4a_1743116100.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 256,798.43 F1 · shares: The original Form 4 filed on January 17, 2025 is being amended to reflect an update in the number of shares acquired on January 16, 2025 pursuant to a dividend reinvestment plan administered by the reporting person's broker. Subsequent to the purchase and the filing of the original Form 4, an adjustment in the number of shares received by the reporting person was made by the broker. This Form 4/A is being filed to update the number of securities held directly and indirectly following this purchase. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:49 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 264.365 | $232.89 | $61,567.96 |
DisclosureSEC source: 0001156375-24-000204 · wk-form4_1735595386.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 255,436.31 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:49 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 11.655 | $232.89 | $2,714.33 |
DisclosureSEC source: 0001156375-24-000204 · wk-form4_1735595386.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,371.84 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 15:43 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 12.357 | $218.50 | $2,700.00 |
DisclosureSEC source: 0001156375-24-000184 · wk-form4_1727451831.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,360.183 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 15:43 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 280.298 | $218.50 | $61,245.11 |
DisclosureSEC source: 0001156375-24-000184 · wk-form4_1727451831.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 255,171.9423 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 00:48 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,237 | $194.10 | $240,101.70 |
DisclosureSEC source: 0001156375-24-000136 · wk-form4_1719449327.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 254,891.6443 F2 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 00:48 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 312.118 | $195.07 | $60,884.86 |
DisclosureSEC source: 0001156375-24-000136 · wk-form4_1719449327.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 253,654.6443 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 00:48 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 13.76 | $195.07 | $2,684.16 |
DisclosureSEC source: 0001156375-24-000136 · wk-form4_1719449327.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,347.826 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 16:49 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 282.061 | $214.71 | $60,561.32 |
DisclosureSEC source: 0001156375-24-000065 · wk-form4_1711558151.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 253,342.5263 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 16:49 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 12.435 | $214.71 | $2,669.92 |
DisclosureSEC source: 0001156375-24-000065 · wk-form4_1711558151.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,334.066 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 22:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 1,331.199 | $202.44 | $269,487.93 |
DisclosureSEC source: 0001156375-24-000004 · wk-form4_1705701805.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 253,060.4653 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 22:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 58.686 | $202.44 | $11,880.39 |
DisclosureSEC source: 0001156375-24-000004 · wk-form4_1705701805.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,321.631 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 20:31 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 266.472 | $210.79 | $56,169.63 |
DisclosureSEC source: 0001156375-23-000203 · wk-form4_1703881885.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 251,729.2663 F1 · shares: 1. Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 20:31 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 11.748 | $210.79 | $2,476.36 |
DisclosureSEC source: 0001156375-23-000203 · wk-form4_1703881885.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,262.945 F1 · shares: 1. Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| September 27, 2023 Filed Oct 6, 2023 13:47 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 279.539 | $199.84 | $55,863.07 |
DisclosureSEC source: 0001156375-23-000171 · wk-form4_1696600032.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 251,462.7943 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| September 27, 2023 Filed Oct 6, 2023 13:47 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 12.324 | $199.84 | $2,462.83 |
DisclosureSEC source: 0001156375-23-000171 · wk-form4_1696600032.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,251.197 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| June 27, 2023 Filed Jun 28, 2023 18:39 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 13.616 | $179.77 | $2,447.75 |
DisclosureSEC source: 0001156375-23-000116 · wf-form4_168797753963533.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,238.873 F2 · shares: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| June 27, 2023 Filed Jun 28, 2023 18:39 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 308.857 | $179.77 | $55,523.22 |
DisclosureSEC source: 0001156375-23-000116 · wf-form4_168797753963533.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 251,183.2553 F2 · shares: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 18:39 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 811 | $178.89 | $145,079.79 |
DisclosureSEC source: 0001156375-23-000116 · wf-form4_168797753963533.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 250,874.3983 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 23:28 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 194.8873 | $186.45 | $36,336.74 |
DisclosureSEC source: 0001156375-23-000057 · wf-form4_168013247189673.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 250,063.3983 F1 · shares: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 23:28 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 297.835 | $185.32 | $55,194.78 |
DisclosureSEC source: 0001156375-23-000057 · wf-form4_168013247189673.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 249,868.511 F1 · shares: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 23:28 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 13.13 | $185.32 | $2,433.25 |
DisclosureSEC source: 0001156375-23-000057 · wf-form4_168013247189673.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,225.257 F1 · shares: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 21:41 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 1,243.923 | $175.98 | $218,905.57 |
DisclosureSEC source: 0001156375-23-000004 · wf-form4_167425087815999.xml · nonDerivative · entry 4 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 249,375.984 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 21:41 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 54.839 | $175.98 | $9,650.57 |
DisclosureSEC source: 0001156375-23-000004 · wf-form4_167425087815999.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,212.127 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| January 18, 2023 Filed Mar 29, 2023 23:00 UTC Amendment | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 1,243.923 | $175.98 | $218,905.57 |
DisclosureSEC source: 0001156375-23-000055 · wf-form4a_168013079174839.xml · nonDerivative · entry 4 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 249,570.676 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. F2 · balance_after: This Form 4/A is being filed solely to correct the number of securities held indirectly following this purchase. Read SEC document |
| January 18, 2023 Filed Mar 29, 2023 23:00 UTC Amendment | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 54.839 | $175.98 | $9,650.57 |
DisclosureSEC source: 0001156375-23-000055 · wf-form4a_168013079174839.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,212.127 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| December 29, 2022 Filed Mar 29, 2023 22:37 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 194.6919 | $168.67 | $32,838.68 |
DisclosureSEC source: 0001156375-23-000053 · wf-form5_168012945446413.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 248,326.7529 F1 · shares: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| December 28, 2022 Filed Jan 20, 2023 21:41 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 289.366 | $168.11 | $48,645.32 |
DisclosureSEC source: 0001156375-23-000004 · wf-form4_167425087815999.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 248,132.061 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| December 28, 2022 Filed Jan 20, 2023 21:41 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 12.757 | $168.11 | $2,144.58 |
DisclosureSEC source: 0001156375-23-000004 · wf-form4_167425087815999.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,157.288 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.